Influvac Tetra Indications/Uses

Prophylaxis of influenza, especially those who run an increased risk of associated complications.
Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (Influvac Tetra) is indicated in adults and children from 6 months of age.
The use of Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (Influvac Tetra) should be based on official recommendations.
Vaccination is particularly recommended for the following categories of patients, depending on national immunization policies: Persons aged ≥65 years, regardless their health condition.
Adults and children from 6 months of age with chronic disorders of the pulmonary or cardiovascular systems, including asthma.
Adults and children from 6 months of age with chronic metabolic diseases such as diabetes mellitus.
Adults and children from 6 months of age with chronic renal dysfunction.
Adults and children from 6 months of age with immunodeficiencies due to disease or immunosuppressant medication (e.g., cytostatics or corticosteroids) or radiotherapy.
Children from 6 months of age who receive long-term acetylsalicylic acid containing medication, and might therefore be at risk for developing Reye's syndrome following an influenza infection.